Characteristics of the tree shrew humoral immune system.


Journal

Molecular immunology
ISSN: 1872-9142
Titre abrégé: Mol Immunol
Pays: England
ID NLM: 7905289

Informations de publication

Date de publication:
11 2020
Historique:
received: 03 07 2020
revised: 02 09 2020
accepted: 07 09 2020
pubmed: 30 9 2020
medline: 1 12 2020
entrez: 29 9 2020
Statut: ppublish

Résumé

Preclinical studies require an immune response similar to that of humans in a small animal model that is convenient to operate. Based on genome alignment, tree shrews are small animals considered to be more similar to primates than are rodents, and many human disease models have been established with tree shrews. However, the characteristics of the humoral immune response of tree shrews remain to be elucidated. In this study, the genetic sequence of the heavy chain constant region of tree shrew immunoglobulin (Ig) was complemented, and the results of immunoglobulin domain homology and transcriptome analysis showed that the tree shrew genome encodes only four classes of antibodies and does not encode IgD. The oldest IgM antibody has the highest homology with primates. After the complete sequence of each type of antibody was obtained, the tree shrew antibody protein was further expressed and purified by in vitro recombination, and an IgG quantitative evaluation system was established. The highly effective immuno protective effect induced by HSV-1 infection and the significant bactericidal effect induced by Neisseria meningitidis group C polysaccharide immunization showed that tree shrews exhibited immune responses more similar to humans than to mice. This may provide better predictive value for vaccine preclinical research.

Identifiants

pubmed: 32992149
pii: S0161-5890(20)30485-5
doi: 10.1016/j.molimm.2020.09.009
pii:
doi:

Substances chimiques

DNA, Complementary 0
Immunoglobulin G 0
Recombinant Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

175-185

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Jingjing Zhang (J)

Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research and Development of Severe Infectious Disease, 935 Jiaoling Road, Kunming, 650118, Yunnan, China.

Hongjian Xiao (H)

Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research and Development of Severe Infectious Disease, 935 Jiaoling Road, Kunming, 650118, Yunnan, China.

Yanwei Bi (Y)

Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research and Development of Severe Infectious Disease, 935 Jiaoling Road, Kunming, 650118, Yunnan, China.

Qiong Long (Q)

Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research and Development of Severe Infectious Disease, 935 Jiaoling Road, Kunming, 650118, Yunnan, China.

Yue Gong (Y)

Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research and Development of Severe Infectious Disease, 935 Jiaoling Road, Kunming, 650118, Yunnan, China.

Jiejie Dai (J)

Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research and Development of Severe Infectious Disease, 935 Jiaoling Road, Kunming, 650118, Yunnan, China.

Ming Sun (M)

Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research and Development of Severe Infectious Disease, 935 Jiaoling Road, Kunming, 650118, Yunnan, China.

Wei Cun (W)

Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research and Development of Severe Infectious Disease, 935 Jiaoling Road, Kunming, 650118, Yunnan, China. Electronic address: cun@imbcams.com.cn.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH